Shanghai BioBond Pharmaceutical Co. Ltd, located in Shanghai Zhangjiang Hi-tech Park, was founded by a group of professors from Shanghai Institute of Materia and Medica, with the vision to exploit new drugs in nervous drug and antitumor areas.
Biobond is an experienced team in R&D of synthesis, pharmacology, drug formulation, drug analysis scientists. Our business include:
1, Supply key intermediates of API for pharmaceutical company following API’s GMP system;
2, Design and implement of Pre-clinical research for pharmaceutical company;
3, Develop new drugs, with the mission to service for human health.
products:
Olaparib intermediates CAS NO.: 61260-15-9; 218301-22-5 763114-25-6 763114-26-7 59878-57-8 1021298-67-8 1021298-68-9
Linezolid intermediate 496031-57-3 93246-53-8
Ranolazine intermediates 5294-61-1 2210-74-4
Niraparib intermediates 138229-59-1 19733-56-3 875798-79-1 1196713-21-9 1263284-59-8 1171197-20-8
CAS NO.: 446-32-2; 928149-12-6 ;
2-Thiofenacetic acid 1918-77-0
N1-(4-chlorophenyl)benzene-1,2-diamine 68817-71-0
chloromethyl dodecanoate 61413-67-0
Dimethyl chloromalonate 28868-76-0
3-Amino-1-adamantanol 702-82-9
Ethyl 7-chloro-2-oxoheptanoate 78834-75-0
chloromethyl dodecanoate 61413-67-0
